1. Home
  2. EBS vs HCAT Comparison

EBS vs HCAT Comparison

Compare EBS & HCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • HCAT
  • Stock Information
  • Founded
  • EBS 1998
  • HCAT 2008
  • Country
  • EBS United States
  • HCAT United States
  • Employees
  • EBS N/A
  • HCAT N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • HCAT Computer Software: Programming Data Processing
  • Sector
  • EBS Health Care
  • HCAT Technology
  • Exchange
  • EBS Nasdaq
  • HCAT Nasdaq
  • Market Cap
  • EBS 459.6M
  • HCAT 464.4M
  • IPO Year
  • EBS 2006
  • HCAT 2019
  • Fundamental
  • Price
  • EBS $11.98
  • HCAT $8.40
  • Analyst Decision
  • EBS Buy
  • HCAT Buy
  • Analyst Count
  • EBS 3
  • HCAT 10
  • Target Price
  • EBS $14.00
  • HCAT $11.56
  • AVG Volume (30 Days)
  • EBS 1.3M
  • HCAT 486.0K
  • Earning Date
  • EBS 11-06-2024
  • HCAT 11-06-2024
  • Dividend Yield
  • EBS N/A
  • HCAT N/A
  • EPS Growth
  • EBS N/A
  • HCAT N/A
  • EPS
  • EBS N/A
  • HCAT N/A
  • Revenue
  • EBS $1,125,500,000.00
  • HCAT $302,062,000.00
  • Revenue This Year
  • EBS $6.83
  • HCAT $5.98
  • Revenue Next Year
  • EBS $2.50
  • HCAT $11.42
  • P/E Ratio
  • EBS N/A
  • HCAT N/A
  • Revenue Growth
  • EBS 2.05
  • HCAT 4.15
  • 52 Week Low
  • EBS $1.42
  • HCAT $5.42
  • 52 Week High
  • EBS $15.10
  • HCAT $11.41
  • Technical
  • Relative Strength Index (RSI)
  • EBS 66.68
  • HCAT 64.84
  • Support Level
  • EBS $8.66
  • HCAT $7.41
  • Resistance Level
  • EBS $12.73
  • HCAT $8.05
  • Average True Range (ATR)
  • EBS 0.72
  • HCAT 0.48
  • MACD
  • EBS 0.13
  • HCAT 0.03
  • Stochastic Oscillator
  • EBS 60.19
  • HCAT 88.96

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

Share on Social Networks: